Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Colorectal Neoplasms

Free Subscription 06.05.2024 1 Am J Surg 1 Ann Oncol 2 Ann Surg Oncol 1 Anticancer Res 4 BMC Cancer 1 BMC Gastroenterol 3 Br J Cancer 2 Cancer 3 Clin Cancer Res 7 Dis Colon Rectum 1 Eur J Surg Oncol 2 Gastroenterology 3 Gastrointest Endosc 8 Int J Cancer 4 Int J Colorectal Dis 1 J Clin Oncol 1 J Surg Oncol 1 Lancet Oncol 1 PLoS One 1 World J Surg

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. EDWARDS A, Monroe R, Amram O, Kumar A, et al
   Distance to endoscopy services amplifies racial inequities in colorectal cancer mortality in Washington state.
   Am J Surg. 2024 Apr 18:S0002-9610(24)00198-3. doi: 10.1016/j.amjsurg.2024.
   PubMed         Abstract available
   
   

   
   Ann Oncol

2. BRENNER H, Niedermaier T, Hoffmeister M
   Sensitivity of a blood ctDNA-based multimodal test for the detection of advanced colorectal neoplasms.
   Ann Oncol. 2024;35:476-477.
   PubMed        
   
   

   
   Ann Surg Oncol

3. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
   Disparities in Colorectal Cancer Screening.
   Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15296.
   PubMed        
   
   
4. BEKKI T, Shimomura M, Yano T, Akabane S, et al
   Reply to Letter to Editor Regarding Article "C-Reactive Protein/Albumin Ratio is an Independent Risk Factor for Recurrence and Survival Following Curative Resection of Stage I-III Colorectal Cancer in Older Patients".
   Ann Surg Oncol. 2024 Apr 28. doi: 10.1245/s10434-024-15300.
   PubMed        
   
   

   
   Anticancer Res

5. WAGNER D, Karitnig R, Wienerroither V, Hau HM, et al
   Sarcopenic Obesity Promotes Recurrence in Patients Undergoing Resection for Colorectal Liver Metastases (CRLM).
   Anticancer Res. 2024;44:2177-2183.
   PubMed         Abstract available
   
   

   
   BMC Cancer

6. CUNNINGHAM R, Stanley J, Imlach F, Haitana T, et al
   Cancer diagnosis after emergency presentations in people with mental health and substance use conditions: a national cohort study.
   BMC Cancer. 2024;24:546.
   PubMed         Abstract available
   
   
7. ALSADHAN N, Alhurishi SA, Pujades-Rodriguez M, Shuweihdi F, et al
   Demographic and clinical characteristics associated with advanced stage colorectal cancer: a registry-based cohort study in Saudi Arabia.
   BMC Cancer. 2024;24:533.
   PubMed         Abstract available
   
   
8. RAO L, Xu P, Zhang G, Zu R, et al
   Prognostic value of creatine kinase (CK)-MB to total-CK ratio in colorectal cancer patients after curative resection.
   BMC Cancer. 2024;24:543.
   PubMed         Abstract available
   
   
9. WU Y, Chen C, Hua X, Zhao C, et al
   Association of the TRIM family protein with survival outcomes and clinicopathological features in colorectal cancer: a systematic review and meta-analysis.
   BMC Cancer. 2024;24:537.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

10. BREZINA S, Leeb G, Baierl A, Graf E, et al
    Evaluation of the "Burgenland PREvention trial of colorectal cancer Disease with ImmunologiCal Testing" (B-PREDICT)-a population-based colorectal cancer screening program.
    BMC Gastroenterol. 2024;24:149.
    PubMed         Abstract available
    
    

    
    Br J Cancer

11. VILLAREAL LB, Falcon DM, Xie L, Xue X, et al
    Hypoxia-inducible factor 3alpha1 increases epithelial-to-mesenchymal transition and iron uptake to drive colorectal cancer liver metastasis.
    Br J Cancer. 2024 May 1. doi: 10.1038/s41416-024-02699.
    PubMed         Abstract available
    
    
12. QIAO L, Liu Y, Yang Q
    Comment on: "Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial".
    Br J Cancer. 2024;130:1432-1433.
    PubMed        
    
    
13. CAI J, Lin K, Luo T, Weng J, et al
    Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial.
    Br J Cancer. 2024;130:1434-1440.
    PubMed         Abstract available
    
    

    
    Cancer

14. HOEHN RS, Ammori JB, Rothermel LD, Winter JM, et al
    Providing context for the HIPECT4 results.
    Cancer. 2024;130:1727-1729.
    PubMed        
    
    
15. LIU YL, Weigelt B
    A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancers.
    Cancer. 2024 Feb 29. doi: 10.1002/cncr.35267.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

16. PARIKH AR, Chee BH, Tsai J, Rich TA, et al
    Minimal Residual Disease using a Plasma-Only Circulating Tumor DNA Assay to Predict Recurrence of Metastatic Colorectal Cancer Following Curative Intent Treatment.
    Clin Cancer Res. 2024 May 2. doi: 10.1158/1078-0432.CCR-23-3660.
    PubMed         Abstract available
    
    
17. WU C, Pai RK, Kosiorek H, Banerjee I, et al
    Improved Risk-Stratification Scheme for Mismatch-Repair Proficient Stage II Colorectal Cancers Using the Digital Pathology Biomarker QuantCRC.
    Clin Cancer Res. 2024;30:1811-1821.
    PubMed         Abstract available
    
    
18. KHUSHMAN MM, Toboni MD, Xiu J, Manne U, et al
    Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations.
    Clin Cancer Res. 2024;30:1906-1915.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

19. CUSTERS PA, Beets GL, Bach SP, Blomqvist LK, et al
    An International Expert-Based Consensus on the Definition of a Clinical Near-Complete Response After Neoadjuvant (Chemo)radiotherapy for Rectal Cancer.
    Dis Colon Rectum. 2024;67:782-795.
    PubMed         Abstract available
    
    
20. CHURCH J
    Being a Colorectal Geneticist.
    Dis Colon Rectum. 2024;67:743-747.
    PubMed        
    
    
21. HE S, Zhang J, Wang R, Li L, et al
    Long-term Changes in Low Anterior Resection Syndrome in Survivors of Rectal Cancer: Longitudinal Follow-up of a Randomized Controlled Trial.
    Dis Colon Rectum. 2024;67:834-840.
    PubMed         Abstract available
    
    
22. NEPAL P, Zafar MH, Liu LC, Xu Z, et al
    Socioeconomic Disparities in Anal Cancer: Effect on Treatment Delay and Survival.
    Dis Colon Rectum. 2024;67:773-781.
    PubMed         Abstract available
    
    
23. WALLER JH, van Kessel CS, Solomon MJ, Lee PJ, et al
    Outcomes Following Pelvic Exenteration for Locally Recurrent Rectal Cancer With and Without En Bloc Sacrectomy.
    Dis Colon Rectum. 2024;67:796-804.
    PubMed         Abstract available
    
    
24. IWAMOTO M, Makutani Y, Ushijima H, Ogawa R, et al
    Cranial-First Approach in Robot-Assisted Right Hemicolectomy.
    Dis Colon Rectum. 2024;67:e358.
    PubMed        
    
    
25. LEE TG, Ahn HM, Shin HR, Choi MJ, et al
    Totally Extraperitoneal Approach for Recurrent Lateral Pelvic Lymph Nodes After Rectal Cancer Surgery.
    Dis Colon Rectum. 2024;67:e360-e361.
    PubMed        
    
    

    
    Eur J Surg Oncol

26. ZHENG Y, Wang J, Sun L
    Reply to: Unveiling controversies: The role of HIPEC in colorectal cancer peritoneal metastasis.
    Eur J Surg Oncol. 2024 Apr 23:108344. doi: 10.1016/j.ejso.2024.108344.
    PubMed        
    
    

    
    Gastroenterology

27. DE KLAVER W, van der Vlugt M, Spaander MCW, Bossuyt PM, et al
    Risk of cancers proximal to the colon in fecal immunochemical test positive screenees in a colorectal cancer screening program.
    Gastroenterology. 2024 Apr 30:S0016-5085(24)00493.
    PubMed         Abstract available
    
    
28. ZHAO S, He Z, Sui X, Zhang S, et al
    Real-world Stool-based mSDC2 Test Improved Detection of Advanced Colorectal Neoplasia for Colorectal Cancer Screening: A Prospective, Multicenter, Community-based Study.
    Gastroenterology. 2024 Apr 24:S0016-5085(24)00484.
    PubMed        
    
    

    
    Gastrointest Endosc

29. PASAM RT, Chandan S, Mohan BP
    Endoscopic techniques to reduce recurrence after EMR of large nonpedunculated colorectal polyps.
    Gastrointest Endosc. 2024;99:863-864.
    PubMed        
    
    
30. MARANKI J
    Improving colonoscopy quality: growing evidence to support adenomas per colonoscopy as a standard quality indicator.
    Gastrointest Endosc. 2024;99:796-797.
    PubMed        
    
    
31. LI L
    The superiority of blue-light imaging and narrow-band imaging over white-light imaging in the detection of proximal colonic lesions.
    Gastrointest Endosc. 2024;99:864-865.
    PubMed        
    
    

    
    Int J Cancer

32. VAN LANEN AS, Kok DE, Wesselink E, Derksen JWG, et al
    Associations between low- and high-fat dairy intake and recurrence risk in people with stage I-III colorectal cancer differ by sex and primary tumour location.
    Int J Cancer. 2024 May 3. doi: 10.1002/ijc.34959.
    PubMed         Abstract available
    
    
33. BECERRA-TOMAS N, Markozannes G, Cariolou M, Balducci K, et al
    Post-diagnosis adiposity and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
    Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34905.
    PubMed         Abstract available
    
    
34. MARKOZANNES G, Becerra-Tomas N, Cariolou M, Balducci K, et al
    Post-diagnosis physical activity and sedentary behaviour and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
    Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34903.
    PubMed         Abstract available
    
    
35. CHAN DSM, Cariolou M, Markozannes G, Balducci K, et al
    Post-diagnosis dietary factors, supplement use and colorectal cancer prognosis: A Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis.
    Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34906.
    PubMed         Abstract available
    
    
36. TSILIDIS KK, Markozannes G, Becerra-Tomas N, Cariolou M, et al
    Post-diagnosis adiposity, physical activity, sedentary behaviour, dietary factors, supplement use and colorectal cancer prognosis: Global Cancer Update Programme (CUP Global) summary of evidence grading.
    Int J Cancer. 2024 May 1. doi: 10.1002/ijc.34904.
    PubMed         Abstract available
    
    
37. ZHANG Y, Win AK, Makalic E, Buchanan DD, et al
    Associations between pathological features and risk of metachronous colorectal cancer.
    Int J Cancer. 2024 Apr 27. doi: 10.1002/ijc.34979.
    PubMed         Abstract available
    
    
38. LINDQUIST S, Frederiksen K, Petersen LK, Kjaer SK, et al
    The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples.
    Int J Cancer. 2024 Feb 28. doi: 10.1002/ijc.34896.
    PubMed         Abstract available
    
    
39. HAMMARSTROM K, Nunes L, Mathot L, Mezheyeuski A, et al
    Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer.
    Int J Cancer. 2024;155:40-53.
    PubMed         Abstract available
    
    

    
    Int J Colorectal Dis

40. LOFFLER L, Gogenur I, Gogenur M
    Correlations between preoperative statin treatment with short- and long-term survival following colorectal cancer surgery: a propensity score-matched national cohort study.
    Int J Colorectal Dis. 2024;39:60.
    PubMed         Abstract available
    
    
41. KONG J, Wu MQ, Yan S, Zhao ZF, et al
    Single-incision plus one-port laparoscopy surgery versus conventional multi-port laparoscopy surgery for colorectal cancer: a systematic review and meta-analysis.
    Int J Colorectal Dis. 2024;39:62.
    PubMed         Abstract available
    
    
42. NIKOLIC A, Tranter-Entwistle I, McCombie A, Connor S, et al
    The utility of synoptic operation reports in colorectal surgery: a systematic review.
    Int J Colorectal Dis. 2024;39:63.
    PubMed         Abstract available
    
    
43. HARDT J, Seyfried S, Brodrecht H, Khalil L, et al
    Remote ischemic preconditioning versus sham-control for prevention of anastomotic leakage after resection for rectal cancer (RIPAL trial): a pilot randomized controlled, triple-blinded monocenter trial.
    Int J Colorectal Dis. 2024;39:65.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

44. 
    Erratum: Predicting Functional Recovery and Quality of Life in Older Patients Undergoing Colorectal Cancer Surgery: Real-World Data From the International GOSAFE Study.
    J Clin Oncol. 2024 Apr 30:JCO2400763. doi: 10.1200/JCO.24.00763.
    PubMed        
    
    

    
    J Surg Oncol

45. NAKAO E, Honda M, Uesugi N, Osakabe M, et al
    Evaluation of the prognostic impact of pathologic tumor regression grade on patients with colorectal cancer after preoperative chemoradiotherapy.
    J Surg Oncol. 2024 May 1. doi: 10.1002/jso.27662.
    PubMed         Abstract available
    
    

    
    Lancet Oncol

46. ERCAN AB, Aronson M, Fernandez NR, Chang Y, et al
    Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
    Lancet Oncol. 2024;25:668-682.
    PubMed         Abstract available
    
    

    
    PLoS One

47. MAEKAWA M, Tanaka A, Ogawa M, Roehrl MH, et al
    Propensity score matching as an effective strategy for biomarker cohort design and omics data analysis.
    PLoS One. 2024;19:e0302109.
    PubMed         Abstract available
    
    

    
    World J Surg

48. BEN-YAACOV A, Levine O, Schtrechman G, Adileh M, et al
    Extremely high peritoneal cancer index in colorectal peritoneal metastases demonstrates safety and overall survival benefit in selected patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy.
    World J Surg. 2024;48:871-878.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.